Anti-class II antibodies in kidney transplant patients.
Rebibou
J M
JM
ETS de Franche-Comté and Service de Néphrologie-Transplantation, Besançon, France.
Bittencourt
M C
MC
Ducloux
D
D
Chabod
J
J
Thévenin
C
C
Chalopin
J M
JM
Hervé
P
P
Tiberghien
P
P
D000920:Antibody-Dependent Cell Cytotoxicity; D001402:B-Lymphocytes / Q000276:immunology; D003404:Creatinine / Q000097:blood; D006084:Graft Rejection / Q000276:immunology; D006085:Graft Survival / Q000276:immunology; D006681:HLA-D Antigens / Q000276:immunology*; D006650:Histocompatibility Testing; D006801:Humans; D007518:Isoantibodies / Q000097:blood*; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D011183:Postoperative Complications / Q000276:immunology; D012086:Reoperation; D013601:T-Lymphocytes / Q000276:immunology; D017211:Treatment Failure
D006681:HLA-D Antigens; D007518:Isoantibodies; D003404:Creatinine